Fasciocutaneous flaps as a group have been maligned more often for fear of
potential donor-site morbidity than any concern for reliability. Typically,
this is related to limitations imposed by the skin graft necessary to clos
e most such donor sites, as admittedly has been required for the majority (
52 percent) of our 313 flaps over the past 2 decades. Nevertheless, 48 perc
ent did not require skin grafts, reflecting the adoption of strategies that
evolved to minimize this shortcoming. These included use of fascia-only fl
aps, primary closure with small composite flaps, direct closure possible by
use of rotation or advancement flaps ol a second flap, or a delayed closur
e utilizing either pretransfer or posttransfer tissue expansion. Donor-site
complications were actually fewest when a skin graft primary closure was p
ossible and occurred at the same rate regardless of body region. However, b
ecause the skin-grafted donor site was always a cosmetic compromise, a syst
ematic approach to circumvent its use whenever possible is emphasized as a
valuable tool to enhance the role of fasciocutaneous flaps as a vascularize
d flap alternative.